Tumor-specific inhibition of DNA synthesis and cell proliferation by a factor from bovine placenta — possible mechanism  by Letnansky, Karl
Volume 171. number 1 FEBS 1477 June 1984 
Tumor-specific inhibition of DNA synthesis and cell 
proliferation by a factor from bovine placenta - possible 
mechanism 
Karl Letnansky 
Institute for Applied and Experimental Oncology, University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria 
Received 2 April 1984 
A ~l~~tide isolated from the maternal part of bovine placentas inhibits si~~c~~y the incorporation 
of thymidine into the DNA of tumor cells, When normal cells are used, this effect is found only to a very 
limited degree. Surface membrane components have been identified which are enriched on tumor cells and 
which are responsible for a better binding of the inhibitor to tumor cells than to normal cells. After 
internalization of the receptor-inhibitor complex, a decrease in the nuclear content of two proteins is 
observed, which might be a requirement for the inhibition of the DNA synthesis. 
DNA synthesis Inhibitor Tumor cell Surface receptor Protein synthesis 
1. INTRODUCTION 
It has been reported that a factor can be isolated 
from bovine maternal placenta which inhibits the 
incorporation of thymidine into the DNA of dif- 
ferent tumors to 43-859’0, but has no significant 
effect on DNA synthesis of normal cells [ 1,2]. The 
development of tumors after the inoculation of 
cells having been incubated with the inhibitor is 
severely impaired, demonstrating the toxicity of 
this component on these cells [3]. The action of 
similar preparations of the same origin on tumor 
induction with 3-methylcholanthrene has also been 
described [4]. 
sequent internalization of the receptor-inhibitor 
complex might be involved in the specific action on 
tumor cells. Actually, binding experiments with 
the inhibitor and with membranes obtained from 
normal and tumor cells, respectively, revealed not 
only the higher binding capacity of tumor mem- 
branes, but also the existence of additional recep- 
tor classes in these membranes as compared to the 
membranes from normal cells 121. 
Investigations into the nature of the inhibitor 
demonstrated that it was inactivated by proteolytic 
enzymes [l] and had an apparent Mr of about 
60000. Inhibitory activity is also associated with a 
polypeptide of roughly 110 kDa, which possibly 
represents a dimeric form. 
Experiments are here described which further 
document he different response of tumor and nor- 
mal cells to the inhibitor. Information concerning 
the receptor sites is now available as well as an 
analysis of nuclear protein components. The latter 
indicates a possible influence of the inhibitor on 
the nuclear content of specific proteins, which 
might be necessary for DNA synthesis. 
2. MATERIALS AND METHODS 
In~bition of thymidine incorporation is ob- The inhibitor was isolated and purified by gel 
served exclusively in experimental systems using filtration (Sephadex G-100), ion-exchange chro- 
intact cells and not in cell-free preparations [2]. matography (Dowex 5OW x 8, eluted with 0.15 M 
This led us to the conclusion that the interaction of NaCl and, after elution of the first peak, with a 
the inhibitor with surface components and the sub- gradient of 0.15 M NaCl10.2 N NH3) and poly- 
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acrylamide gel electrophoresis from the maternal 
part of fresh bovine placenta or from commer- 
ciably available, pharmaceutically used lyophilized 
material (Vitorgan, Stuttgart) as in [2]. Plasma 
membranes were prepared and purified over 
discontinuous sucrose gradients as in [5] from 
various organs and tumors of the rat. Extraction 
of nuclear proteins and separation on 10% 
polyacrylamide urea gels or 10% SDS gels have 
also been described [6-81. Proteins were stained 
using standard procedures with amido black or 
Coomassie blue; carbohydrate residues (on mem- 
brane components) with the periodic acid-Schiff 
reagent [9]. Membrane preparations were 
separated employing the same procedures used for 
nuclear proteins. After electrophoresis, cylindrical 
urea gels were sliced into l-mm thick slices, which 
were fixed overnight with 500~1 of 40% 
methanol-7% acetic acid. After standing for 2 h 
with 1 ml of 10 mM Tris-HCl (pH 7.4), 10 mM 
KCl, 1.5 mM MgCl2 (which was replaced by fresh 
buffer after 1 h), slices were incubated for 2 h at 
room temperature with the inhibitor, which had 
been labeled by reaction with N-succinimidyl- 
[2,3-3H]propionate [2]. Two hundred pl with an 
activity of 1300 cpm were added to each slice. 
After incubation, the slices were washed twice, as 
had been done after the fixation process, and were 
solubilized overnight at 54°C with 200~1 of 30% 
hydrogen peroxide. Samples were counted under 
Bray’s solution in a Packard liquid scintillation 
spectrometer. 
3. RESULTS 
Significant differences in the distribution of in- 
dividual surface membrane components can be 
detected in membranes isolated from liver cells 
compared to those isolated from diethylnitrosa- 
mine-induced hepatoma (not shown) or Yoshida 
ascites arcoma. As shown in fig. 1, this applies not 
only to the amount but also to the chemical nature 
of some of the components. 
For a comparison of molecular sizes, histones 
isolated from rat liver nuclei were run under the 
same conditions. The heavy band at fraction nos 
38-40 corresponds to Hl histones, while the very 
faint band at fractions 52 and 53 corresponds to 
histone H4. The remaining core histones are found 
in fractions 47 and 48. Small amounts of non- 
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Fig.1. Binding of 3H-labeled inhibitor to individual 
membrane fractions from Yoshida tumor cells (Yo- 
Membr.) and liver cells (L-Membr.) after separation on 
10% polyacrylamide urea gels. Separate gels were run 
for staining with amido black and for the binding studies 
as described in section 2. One gel with liver histones (L- 
Hist.), run under the same conditions, served as a 
standard. Direction of the run was from left to right. 
histone proteins in the Mr range between approx. 
50000 and 120000 are spread between fractions 13 
and 26. 
According to the experiment depicted in fig. 1, 3 
main components (fractions 31, 34, 36) are en- 
riched in the tumor membrane preparation. These 
components bind the inhibitor, which has been 
labeled by reaction with N-succinimidyl-[2,3-3H]- 
propionate, to a significant degree. By contrast, 
the same compounds are detected in only small 
amounts in membrane preparations from liver cells 
and bind only negligible amounts of the inhibitor. 
Additional binding sites of the tumor mem- 
branes are obviously associated with the polypep- 
tide contained in fraction 23 of the gel shown in 
fig. 1, and with low-M, components which do not 
stain with amido black, but give intense reactions 
with the Schiff reagent. As demonstrated by the 
separation of liver membranes on SDS-gels (fig.2), 
these carbohydrate-rich fractions are well below 
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Fig.2. Electrophoretic pattern of liver plasma 
membranes after staining with Coomassie blue and 
periodic acid-Schiff reagent. Cross-linked hemoglobin 
served as an M, marker. 
16 kDa. In the range of compounds with high pro- 
tein content, however, only small amounts of car- 
bohydrates are found to be bound to the protein. 
Further experiments were performed to obtain a 
better understanding of the mechanism of the in- 
hibition. Since previous experiments have shown 
that the inhibitor also acts on protein synthesis, the 
patterns of acid-soluble nuclear proteins of 
Yoshida cells incubated for 1 h in the presence or 
absence of the inhibitor were compared. Fig.3 
shows not only the histones isolated from the cells 
after the incubation step by a standard acid extrac- 
tion procedure (the 3 heavy bands in the lower half 
of the gel), but also a series of non-histone proteins 
extracted concomitantly. Among these proteins, 
which have been identified only poorly until now, 
two bands can be located easily in the control gel, 
which are almost completely absent after the in- 
cubation with the inhibitor (arrows). Although 
there has been no experimental evidence to show a 
dependence of the inhibitory action of the isolated 
c 
Fig.3. Electrophoretic pattern of proteins extracted from 
Yoshida tumor cell nuclei [lo] after the incubation of the 
cells for 1 h in the absence (control C) or in the presence 
of the decidua inhibitory factor (DIF). Arrows indicate 
the position of polypeptides disappearing during the 
incubation procedure. 
factor on this decrease in certain proteins, recent 
results [l l-141 might be an indication that one of 
these components participates in the assembly of 
the DNA polymerase-DNA complex. 
4. DISCUSSION 
This paper describes experiments performed to 
attempt an explanation of the inhibitory action of 
a placental component which specifically inhibits 
DNA synthesis in tumor cells. As far as can be said 
at this point, two different processes are involved 
in this effect: (i) the inhibitor is bound to a higher 
degree to the surfaces of tumor cells than to those 
of normal cells, which obviously results in the in- 
ternalization of higher amounts of the 
receptor-inhibitor complex; (ii) the possible 
primary action within the cell is a depletion in one 
(or two) peptide( These peptides must be very 
labile and obviously are not replaced to a sufficient 
degree after the inhibition of protein synthesis. 
Their electrophoretic mobility is very close to that 
of similar components, identified in several tissues 
11 
Volume 17 1, number 1 FEBS LETTERS June 1984 
by authors in [ll-141. These authors inhibited 
protein synthesis with cycloheximide and also 
found a significant reduction in the cellular con- 
tent of a protein which had an M, of about 53000 
as well as a depression of DNA synthesis. They 
concluded that the multienzyme complexes re- 
quired for DNA replication cannot form in the 
absence of this factor. 
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